Leo Pharma is withdrawing the drug Picato (ingenol mebutate), used to treat skin lesions, due to the potential increased risk of skin cancer

27 October 2020 - At Health Canada's request, Leo Pharma is withdrawing Picato from the Canadian market.  ...

Read more →

Fibristal (ulipristal acetate 5 mg tablets) voluntary withdrawal in Canada due to risk of drug-induced liver injury

30 September 2020 - Allergan is working closely with Health Canada to voluntarily withdraw Fibristal (ulipristal acetate 5 mg tablets) ...

Read more →

Health Canada issues warning against use of hydroxychloroquine for COVID-19

26 April 2020 - Health Canada is warning the public of the possible side effects of a drug that U.S. ...

Read more →

B.C. eye doctors warn province of spike in glaucoma cases linked to injections of eye drug

23 May 2019 - Thousands of retinal-disease patients in British Columbia are being exposed to an “increased risk of severe ...

Read more →

Health Canada restricts Allergan's Esmya

15 January 2019 - Health Canada has placed restrictions on Allergan's uterine fibroid treatment Esmya, after discovering a possible link ...

Read more →

Oversight gap at private infusion clinics poses health risk, Ontario documents say

12 November 2018 - The lack of formal oversight at private clinics where medications are administered intravenously could pose risks ...

Read more →